Cargando…
P860: CIRCULATING MULTIPLE MYELOMA CELLS (CMMCS) AS PROGNOSTIC FACTOR AND MINIMAL RESIDUAL DISEASE MARKER IN MM AND SMOULDERING MM PATIENTS
Autores principales: | Vigliotta, Ilaria, Solli, Vincenza, Armuzzi, Silvia, Kanapari, Ajsi, Poletti, Andrea, Taurisano, Barbara, Pistis, Ignazia, Borsi, Enrica, Mazzocchetti, Gaia, Martello, Marina, Rizzello, Ilaria, Pantani, Lucia, Marzocchi, Giulia, Testoni, Nicoletta, Zamagni, Elena, Terracciano, Mario, Del Monaco, Valentina, Garonzi, Marianna, Manaresi, Nicolò, Cavo, Michele, Terragna, Carolina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431104/ http://dx.doi.org/10.1097/01.HS9.0000970344.18232.5c |
Ejemplares similares
-
The ALLgorithMM: How to define the hemodilution of bone marrow samples in lymphoproliferative diseases
por: Vigliotta, Ilaria, et al.
Publicado: (2022) -
Identification of a Maturation Plasma Cell Index through a Highly Sensitive Droplet Digital PCR Assay Gene Expression Signature Validation in Newly Diagnosed Multiple Myeloma Patients
por: Martello, Marina, et al.
Publicado: (2022) -
BoBafit: A copy number clustering tool designed to refit and recalibrate the baseline region of tumors’ profiles
por: Mazzocchetti, G., et al.
Publicado: (2022) -
Clonal and subclonal TP53 molecular impairment is associated with prognosis and progression in multiple myeloma
por: Martello, M., et al.
Publicado: (2022) -
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma
por: Mancuso, Katia, et al.
Publicado: (2023)